Neoadjuvant chemotherapy use trends among older women with breast cancer: 2010-2017.

Hanxi ZhangJamie C BarnerLeticia R MoczygembaKaren L RascatiChanhyun ParkDhatri Kodali

Published in: Breast cancer research and treatment (2022)

Similar to the overall breast cancer population, NAC use increased among a population of older women. NAC was received by most patients with stage III HER2 + disease or TNBC in more recent years and was more common among younger elderly women and those in stage III.

Keyphrases

neoadjuvant chemotherapy
transcription factor
locally advanced
lymph node
sentinel lymph node
polycystic ovary syndrome
squamous cell carcinoma
breast cancer risk
adipose tissue
radiation therapy
metabolic syndrome
early stage
young adults